NM_001144.6:c.1817C>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144.6(AMFR):c.1817C>A(p.Ala606Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A606V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001144.6 missense
Scores
Clinical Significance
Conservation
Publications
- spastic paraplegia 89, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001144.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AMFR | TSL:1 MANE Select | c.1817C>A | p.Ala606Glu | missense | Exon 14 of 14 | ENSP00000290649.5 | Q9UKV5 | ||
| AMFR | c.1799C>A | p.Ala600Glu | missense | Exon 14 of 14 | ENSP00000531501.1 | ||||
| AMFR | c.1787C>A | p.Ala596Glu | missense | Exon 14 of 14 | ENSP00000531502.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249362 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at